Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 10:11 am Sale |
2023-12-31 | 13G | Five9, Inc. FIVN |
VIKING GLOBAL INVESTORS LP | 2,714,117 3.700% |
-933,478 (-25.59%) |
Filing History |
| 2024-02-14 10:00 am Purchase |
2023-12-31 | 13G | Verastem, Inc. VSTM |
VIKING GLOBAL INVESTORS LP | 2,531,829 9.990% |
1,211,173 (+91.71%) |
Filing History |
| 2024-02-14 10:00 am Purchase |
2023-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
VIKING GLOBAL INVESTORS LP | 7,150,826 15.100% |
511,627 (+7.71%) |
Filing History |
| 2024-02-05 4:29 pm Unchanged |
2024-02-01 | 13D | Cazoo Group Ltd CZOOF |
VIKING GLOBAL INVESTORS LP | 21,427 43.800% |
0 (Unchanged) |
Filing History |
| 2024-01-30 4:31 pm Purchase |
2024-01-20 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
VIKING GLOBAL INVESTORS LP | 4,000,000 5.900% |
4,000,000 (New Position) |
Filing History |
| 2024-01-09 4:46 pm Purchase |
2024-01-05 | 13G | Standard BioTools Inc. LAB |
VIKING GLOBAL INVESTORS LP | 29,106,365 9.500% |
20,817,249 (+251.14%) |
Filing History |
| 2024-01-08 4:15 pm Sale |
2024-01-04 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
VIKING GLOBAL INVESTORS LP | 4,247,914 9.900% |
-540,000 (-11.28%) |
Filing History |
| 2024-01-08 4:05 pm Purchase |
2023-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
VIKING GLOBAL INVESTORS LP | 4,787,914 11.200% |
850,000 (+21.59%) |
Filing History |
| 2023-12-08 4:10 pm Purchase |
2023-12-06 | 13D | Cazoo Group Ltd CZOOF |
VIKING GLOBAL INVESTORS LP | 21,427 43.800% |
21,427 (New Position) |
Filing History |
| 2023-11-22 4:15 pm Unchanged |
2023-10-04 | 13D | Standard BioTools Inc. LAB |
VIKING GLOBAL INVESTORS LP | 8,289,116 9.500% |
0 (Unchanged) |
Filing History |
| 2023-11-22 4:15 pm Unchanged |
2023-07-18 | 13D | BridgeBio Pharma, Inc. BBIO |
VIKING GLOBAL INVESTORS LP | 25,120,991 15.700% |
0 (Unchanged) |
Filing History |
| 2023-11-22 4:15 pm Unchanged |
2023-11-03 | 13D | Cazoo Group Ltd CZOO |
VIKING GLOBAL INVESTORS LP | 30,000 7.200% |
0 (Unchanged) |
Filing History |
| 2023-11-07 4:10 pm Unchanged |
2023-11-03 | 13D | Cazoo Group Ltd CZOO |
VIKING GLOBAL INVESTORS LP | 30,000 7.200% |
0 (Unchanged) |
Filing History |
| 2023-11-02 4:30 pm Purchase |
2023-10-23 | 13G | Viking Therapeutics, Inc. VKTX |
VIKING GLOBAL INVESTORS LP | 5,858,532 5.900% |
5,858,532 (New Position) |
Filing History |
| 2023-10-16 4:30 pm Sale |
2023-10-04 | 13D | Standard BioTools Inc. LAB |
VIKING GLOBAL INVESTORS LP | 8,289,116 9.500% |
-34,705 (-0.42%) |
Filing History |
| 2023-10-06 4:15 pm Purchase |
2023-09-26 | 13G | Five9, Inc. FIVN |
VIKING GLOBAL INVESTORS LP | 3,647,595 5.100% |
3,647,595 (New Position) |
Filing History |
| 2023-09-22 5:24 pm Unchanged |
2023-09-20 | 13D | Cazoo Group Ltd CZOO |
VIKING GLOBAL INVESTORS LP | 30,000 7.200% |
0 (Unchanged) |
Filing History |
| 2023-09-21 5:10 pm Purchase |
2023-09-19 | 13G | RayzeBio, Inc. Common Stock RYZB |
VIKING GLOBAL INVESTORS LP | 6,642,700 10.900% |
6,642,700 (New Position) |
Filing History |
| 2023-08-24 4:30 pm Purchase |
2023-08-14 | 13G | Valvoline Inc. VVV |
VIKING GLOBAL INVESTORS LP | 8,338,456 6.000% |
8,338,456 (New Position) |
Filing History |
| 2023-07-19 9:52 pm Sale |
2023-07-18 | 13D | BridgeBio Pharma, Inc. BBIO |
VIKING GLOBAL INVESTORS LP | 25,120,991 15.700% |
-1,500,000 (-5.63%) |
Filing History |